GeoVax Labs, Inc. SEC filings GOVX
GeoVax Labs, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Aug 5, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 27, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DRS/A | Filing | Oct 27, 2026 | — |
| EFFECT | Filing | Sep 23, 2026 | — |
| DRS | Filing | Jul 30, 2026 | — |
| EFFECT | Filing | Jun 3, 2026 | — |
| CORRESP | Letter to the SEC | Jun 1, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2026 | — |
| DEFR14A | Form defr14a | May 18, 2026 | — |
| PRER14A | Filing | May 8, 2026 | — |
| EFFECT | Filing | Apr 21, 2026 | — |
| EFFECT | Filing | Apr 21, 2026 | — |
| EFFECT | Filing | Apr 17, 2026 | — |
| EFFECT | Filing | Apr 17, 2026 | — |
| EFFECT | Filing | Apr 17, 2026 | — |
| EFFECT | Filing | Apr 17, 2026 | — |
| EFFECT | Filing | Apr 17, 2026 | — |
| CORRESP | Letter to the SEC | Apr 17, 2026 | — |
| CORRESP | Letter to the SEC | Apr 17, 2026 | — |
| POS EX | Form pos ex | Apr 17, 2026 | — |
| POS EX | Form pos ex | Apr 17, 2026 | — |
| POS EX | Form pos ex | Apr 17, 2026 | — |
| POS EX | Form pos ex | Apr 17, 2026 | — |
| POS EX | Form pos ex | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2026 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 15, 2025 | — |
| CORRESP | Letter to the SEC | Dec 15, 2025 | — |
| DRS | Filing | Nov 25, 2025 | — |
| 25-NSE | Delisting notice | Sep 29, 2025 | — |
| EFFECT | Filing | Jun 30, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| CORRESP | Letter to the SEC | Jun 27, 2025 | — |
| CORRESP | Letter to the SEC | Jun 25, 2025 | — |
| CORRESP | Letter to the SEC | Jun 23, 2025 | — |
| CORRESP | Letter to the SEC | Jun 20, 2025 | — |
| CORRESP | Letter to the SEC | Jun 17, 2025 | — |
| DRSLTR | Filing | Jun 2, 2025 | — |
| DRS | Filing | Jun 2, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| EFFECT | Filing | Sep 13, 2024 | — |
| EFFECT | Filing | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| EFFECT | Filing | Aug 12, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| EFFECT | Filing | Jun 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| EFFECT | Filing | Mar 13, 2024 | — |
| CORRESP | Letter to the SEC | Mar 11, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2024 | — |
| EFFECT | Filing | Jan 11, 2024 | — |
| CORRESP | Letter to the SEC | Jan 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2024 | — |
| EFFECT | Filing | Mar 24, 2023 | — |
| EFFECT | Filing | Mar 24, 2023 | — |
| EFFECT | Filing | Mar 24, 2023 | — |
| EFFECT | Filing | Jun 24, 2022 | — |
| D | Filing | Jun 22, 2022 | — |
| CORRESP | Letter to the SEC | Jun 22, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2022 | — |
| EFFECT | Filing | Mar 10, 2022 | — |
| EFFECT | Filing | Mar 10, 2022 | — |
| EFFECT | Filing | Feb 10, 2022 | — |
| CORRESP | Letter to the SEC | Feb 8, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2022 | — |
| D | Filing | Jan 20, 2022 | — |
| EFFECT | Filing | Mar 24, 2021 | — |
| AW | Form aw | Mar 24, 2021 | — |
| D | Filing | Feb 25, 2021 | — |
| EFFECT | Filing | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2021 | — |
| D | Filing | Oct 8, 2020 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| 8-A12B | Form 8-a12b | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 23, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2020 | — |
| D | Filing | Jul 6, 2020 | — |
| D/A | Filing | Nov 1, 2019 | — |
| D/A | Filing | Nov 1, 2019 | — |
| D | Filing | Nov 1, 2019 | — |
| D | Filing | Oct 31, 2019 | — |
| PRER14A | Form prer14a | Feb 27, 2019 | — |
| EFFECT | Filing | Apr 2, 2018 | — |
| RW | Form rw | Sep 6, 2017 | — |
| EFFECT | Filing | Apr 3, 2017 | — |
| EFFECT | Filing | Apr 6, 2016 | — |
| CORRESP | Letter to the SEC | Apr 4, 2016 | — |
| CORRESP | Letter to the SEC | Apr 4, 2016 | — |
| AW | Form aw | Apr 4, 2016 | — |
| AW | Form aw | Apr 4, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2016 | — |
| EFFECT | Filing | Mar 30, 2016 | — |
| EFFECT | Filing | Mar 30, 2016 | — |
| EFFECT | Filing | Dec 30, 2015 | — |
| EFFECT | Filing | Sep 10, 2015 | — |
| EFFECT | Filing | Apr 8, 2015 | — |
| EFFECT | Filing | Apr 8, 2015 | — |
| EFFECT | Filing | Apr 8, 2015 | — |
| EFFECT | Filing | Mar 26, 2014 | — |
| EFFECT | Filing | Mar 26, 2014 | — |
| EFFECT | Filing | Jan 15, 2014 | — |
| D | Filing | Dec 23, 2013 | — |
| EFFECT | Filing | Mar 28, 2013 | — |
| EFFECT | Filing | Apr 13, 2012 | — |
| D | Filing | Apr 2, 2012 | — |
| D | Filing | Jan 13, 2012 | — |
| RW | Request for withdrawal | Dec 1, 2011 | — |
| EFFECT | Filing | Nov 8, 2010 | — |
| CORRESP | Letter to the SEC | Nov 3, 2010 | — |
| CORRESP | Letter to the SEC | Jun 29, 2010 | — |
| CORRESP | Letter to the SEC | Jun 25, 2010 | — |
| CORRESP | Letter to the SEC | Apr 28, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2010 | — |
| PRER14A | Filing | Mar 5, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2009 | — |
| CORRESP | Letter to the SEC | Nov 16, 2009 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2009 | — |
| CORRESP | Letter to the SEC | Oct 9, 2009 | — |
| D | Filing | Sep 30, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2009 | — |
| EFFECT | Filing | Jun 1, 2009 | — |
| POS EX | Filing | Apr 3, 2009 | — |
Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GOVX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Smyrna, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 832489
- Former names
- DAUPHIN TECHNOLOGY INC (until Sep 20, 2006)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.